Patient-specific fluid-transport mapping from contrast MRI
This technology analyzes sequences of medical images—such as MRI or CT scans taken over time after a contrast agent is injected—to mathematically reconstruct how fluids actually move through body tissues. Instead of relying on assumed biological models, it uses the image data itself to identify the governing equations that describe fluid transport, then visualizes the results as a map of flow directions and velocities across the tissue. The practical output is a detailed, patient-specific picture of how fluid moves through a tumor or other tissue region. This information can directly inform treatment planning, such as optimizing drug delivery or radiation targeting.
What you could build
A clinical software platform that plugs into existing MRI or CT workflows and automatically generates patient-specific fluid-transport maps from routine contrast imaging—sold to cancer centers, neuro-oncology programs, and radiation therapy planning teams.
Who in Virginia should care
Virginia health systems (Inova, VCU Health, UVA Health) with active oncology or neurology imaging programs, plus defense-adjacent biomedical research contractors in the NoVA corridor.
Readiness: Concept
Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.
Readiness is inferred from the patent text, not from a lab visit.
The record
- Inventors
- Ryan Woodall, Russell Rockne, Jennifer Munson, Jessica Reynolds
- Filed
- Patent pending — filed December 5, 2024
- Status
- Application
- Publication number
- US20260072110A1
Ready to talk?
Virginia Tech Intellectual Properties handles licensing for this technology.
Prosim summaries are generated from public patent text and are not legal advice.